theMednetRegister

Ophthalmology

General Rheumatology   

Questions discussed in this category

How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
This question is part of a collaboration with RheumMadness and is specifically in reference to: Cost Effectiveness of HCQ Screening.
3 Answers available
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
The patient has no extraocular features of a spondyloarthropathy and is on methotrexate. No active eye disease for past 1 year.
2 Answers available
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
No active joint disease, patient on Hydroxychloroquine and Cimzia. Normal ESR/CRP.
1 Answer available
How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?
1 Answer available
How would you approach management of nodular scleritis in the setting of suspected GCA?
Can nodular scleritis be a presenting manifestation of GCA?
1 Answer available
In patients with sicca symptoms and positive SSA/SSB how often do you perform other diagnostic testing such as salivary gland ultrasound, biopsy, Shirmers, ocular staining, stimulated salivary flow, etc?
Is the diagnosis of Sjogren's mostly clinical in a patient with a consistent history and physical with positive serologies?
2 Answers available
What would be your approach to a patient with Scleroderma/Myositis overlap syndrome (+anti-Ku) and active inflammatory eye disease despite high dose mycophenolate?
2 Answers available
Do you hold rituximab for cataract surgery?
If so, when do you recommend timing for the cataract surgery? 
3 Answers available
How would you approach management of incidentally identified unilateral retinal vasculitis with subsequent labs revealing +P-ANCA?
Patient is asymptomatic. Labs showed +P-ANCA 1:160. Negative MPO and PR3.
2 Answers available
In a patient with active spondylarthritis and uveitis who cannot take TNF inhibitors, what is your next agent of choice?
1 Answer available
How do you approach the use of hydroxychloroquine in patients with a history of visual field defect from another cause such as macular degeneration or diabetic retinopathy?
3 Answers available
Would you consider use of belimumab in a patient with SLE with recurrent anterior uveitis who failed other treatment options?
Patient failed topical ocular therapies, methotrexate, azathioprine.
2 Answers available
How do you manage a patient with giant cell arteritis treated with weekly tocilizumab and low dose glucocorticoid who develops sudden vision loss?
2 Answers available
How do you evaluate patients who have panuveitis without any systemic symptoms?
1 Answer available
What is your approach to the workup for an underlying systemic condition in a patient presenting with retinal vasculitis?
1 Answer available
What is your approach to evaluation of underlying autoimmune disease in patients with bilateral scleromalacia?
1 Answer available
How do you diagnose and treat patients who develop uveitis while on bisphosphonate therapy for osteoporosis?
Are there specific features that suggest drug-induced uveitis versus de novo uveitis?
1 Answer available
Do you extrapolate from uveitis treatment pathways when managing other inflammatory eye conditions such as atypical serpiginous choroiditis?
2 Answers available


Papers discussed in this category

Curr Opin Rheumatol,
Retinal vasculitis.
Annals of the rheumatic diseases, 2012-08
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response.
Lupus,
Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
Arthritis Rheumatol, 2020 Jan 07
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy.
J Rheumatol, 2013 Nov 15
Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement.
Arthritis Res Ther, 2005 Mar 01
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
JAMA Ophthalmol, 2015 Oct
Association of systemic lupus erythematosus with uveitis.
JAMA, 2022 Oct 11
Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares.
Front Immunol, 2021 May 14
A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis.
Arthritis Res Ther, 2021 Mar 22
Vision loss in patients with giant cell arteritis treated with tocilizumab.
Int J Environ Res Public Health, 2021 Aug 01
Relationship of Hydroxychloroquine and Ophthalmic Complications in Patients with Type 2 Diabetes in Taiwan.
Ophthalmology and therapy, 2023 Aug 21
Cataract Surgery Outcomes in Patients with Non-ocular Autoimmune Disease.
Lancet (London, England), 2025 Jan 25
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial.
Arthritis Rheumatol, 2016 Oct 26
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.
Arthritis care & research, 2017 Oct 09
Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy.
The Journal of rheumatology, 2021 May 01
Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness in Primary Sjögren Syndrome.
Arthritis & rheumatology (Hoboken, N.J.), 2021 Apr 26
American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.
Ophthalmology, 2016-06
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Related Topics in Ophthalmology

Copyright © 2025 theMednet
All Rights Reserved.